ArticleScientific reports2026
Differential effects of voluntary exercise and Totum-448, a plant-based formulation, in a hamster model of MASLD.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Lifestyle interventions constitute first-line strategies for the management of metabolic dysfunction-associated steatotic liver disease (MASLD), with dietary modification and increased physical activity forming the core evidence-based approaches. In this framework, plant-based supplements are being investigated as potential adjunctive strategies. Totum-448, a polyphenol-rich plant formulation, has shown promising effects in preclinical studies. Here, we evaluated the effects of Totum-448, voluntary exercise (Vex), and their combination in a hamster model of MASLD. Fifty-four male golden Syrian hamsters were fed either a normal diet (ND) or a Western diet (WD) for six weeks. WD-fed animals were then randomized to receive WD alone, WD supplemented with Totum-448 (5% w/w), WD with Vex, or WD with both interventions for an additional five weeks. We hypothesized that only the combined intervention would elicit measurable benefits. Contrary to this hypothesis, distinct effects were observed for each intervention: Totum-448 reduced circulating lipid levels and downregulated hepatic markers of inflammation and fibrosis, whereas Vex improved body composition, increased energy expenditure, and reduced hepatic lipid content. No significant improvements were detected in histological markers of inflammation or fibrosis. The combined intervention did not provide additional benefits beyond those of the individual interventions. In conclusion, Totum-448 and Vex exert complementary effects in MASLD. Although no additive effects were observed, the combined intervention provided the broadest overall protection by preserving the benefits of each intervention alone. These findings support the relevance of combining exercise with plant-based nutritional strategies in the management of MASLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.